510(k) Report

FDA applicant

Kawasumi Laboratories Co., Ltd.

Tokyo, JP29 decisions1987–20191 recall

FDA records 29 decisions for Kawasumi Laboratories Co., Ltd. (Tokyo, JP) from 1987 to 2019: 29 510(k) clearances. Most are in product codes FPA (Set, Administration, Intravascular) and FMI (Needle, Hypodermic, Single Lumen). Its devices cite 15 predicates, 8 of them its own earlier devices. 1 recall is linked to its devices.

FDA’s records also spell it “Kawasumi Laboratories, Inc.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Kawasumi Laboratories Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2019

2008: 12010: 22013: 12018: 12019: 2
2007high 2 (2010) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Kawasumi Laboratories Co., Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Kawasumi Laboratories Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Kawasumi”

FDA records each applicant name separately; these may or may not be the same firm.